Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.,Epilepsy Currents

当前位置： X-MOL 学术 › Epilepsy Curr. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.
Epilepsy Currents ( IF 3.6 ) Pub Date : 2020-01-15 , DOI: 10.1177/1535759719895274
Devin K Binder ₁ , Detlev Boison ₂ , Tore Eid ₃ , Wayne N Frankel ₄ , Ana Mingorance ₅ , Bret N Smith ₆ , Penny A Dacks ₇ , Vicky Whittemore ₈ , Annapurna Poduri ₉ ,

Affiliation

Division of Biomedical Sciences, School of Medicine, Center for Glial-Neuronal Interactions, University of California, Riverside, CA, USA.
Department of Neurosurgery, Robert Wood Johnson and New Jersey Medical Schools, Rutgers University, Piscataway, NJ, USA.
Department of Laboratory Medicine, Neurosurgery and Molecular Physiology, Yale University, New Haven, CT, USA.
Department of Genetics & Development, Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Dracaena Consulting SL, Madrid, Spain.
Department of Neuroscience, University of Kentucky College of Medicine, Lexington, KY, USA.
American Epilepsy Society, Chicago, IL, USA.
Division of Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Area II of the 2014 Epilepsy Research Benchmarks aims to establish goals for preventing the development and progression of epilepsy. In this review, we will highlight key advances in Area II since the last summary of research progress and opportunities was published in 2016. We also highlight areas of investigation that began to develop before 2016 and in which additional progress has been made more recently.

中文翻译：